Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 18 nM | Antiangiogenic activity in HUVEC assessed as inhibition of VEGF-induced proliferation after 3 days by WST-8 assay | ChEMBL. | 21247763 |
Inhibition (ADMET) | = 29 % | Inhibition of CYP3A4 at 10 uM using testosterone as substrate | ChEMBL. | 21247763 |
Inhibition (functional) | = 79 % | Antitumor activity against mouse B16 cells xenografted in C57BL/6N mouse assessed as tumor growth at 100 mg/kg, po qd for 10 days relative to control | ChEMBL. | 21247763 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 21247763 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.